JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4058 BIIB021

Target: HSP90

Summary: Hsp90 inhibitor,selective and competitive

insoluble in EtOH; insoluble in H2O; ≥14.95 mg/mL
A4153 BMN 673
7 Citation

Summary: Potent PARP inhibitor
A2583 Lactacystin (Synthetic)
1 Citation

Target: Proteasome

Summary: Proteasome inhibitor

≥20 mg/mL
A4072 MK-2048

Summary: Integrase inhibitor for HIV-1,second generation

≥10.55 mg/mL

insoluble in H2O
A4166 EPZ5676
2 Citation

Target: DOT1L

Summary: DOT1L inhibitor,potent and SAM competitive

≥28.15 mg/mL
A4111 VX-680 (MK-0457,Tozasertib)
1 Citation

Target: Aurora Kinases

Summary: Aurora kinase inhibitor

≥23.25 mg/mL
A4034 Linagliptin (BI-1356)

Summary: DDP-4 inhibitor,highly potent and competitive

insoluble in H2O; insoluble in EtOH; ≥17.85 mg/mL
A2585 MG-132
136 Citation

Target: Proteasome

Summary: proteasome inhibitor

≥23.78 mg/mL
A4051 NSC 405020
1 Citation

Target: MMP

Summary: MT1-MMP inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4209 NSC 207895 (XI-006)

Target: MDMX

Summary: MDMX inhibitor,anti-cancer agent